Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

J Cereb Blood Flow Metab. 2023 Jan;43(1):26-43. doi: 10.1177/0271678X221135061. Epub 2022 Oct 24.

Abstract

Neurodegeneration refers to the selective and progressive loss-of-function and atrophy of neurons, and is present in disorders such as Alzheimer's, Huntington's, and Parkinson's disease. Although each disease presents with a unique pattern of neurodegeneration, and subsequent disease phenotype, increasing evidence implicates alterations in energy usage as a shared and core feature in the onset and progression of these disorders. Indeed, disturbances in energy metabolism may contribute to the vulnerability of neurons to apoptosis. In this review we will outline these disturbances in glucose metabolism, and how fatty acids are able to compensate for this impairment in energy production in neurodegenerative disorders. We will also highlight underlying mechanisms that could contribute to these alterations in energy metabolism. A greater understanding of these metabolism-neurodegeneration processes could lead to improved treatment options for neurodegenerative disease patients.

Keywords: Alzheimer’s disease; Energy metabolism; Huntington’s disease; Parkinson’s disease; insulin resistance.

Publication types

  • Review

MeSH terms

  • Glucose
  • Humans
  • Neurodegenerative Diseases*

Substances

  • Glucose